Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Curmasip
- Development stage
- Unknown
- Lead developer
- Goldline Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Curmasip is a curcumin-based nutraceutical product developed and marketed by Goldline Pharmaceuticals within its specialty oncology division. Formulated as an oral liquid or 'sip,' it leverages the therapeutic properties of curcumin, the active polyphenol found in turmeric (*Curcuma longa*). Curcumin is widely recognized in integrative oncology for its ability to modulate multiple molecular pathways involved in inflammation and carcinogenesis, including the inhibition of nuclear factor kappa B (NF-kB), cyclooxygenase-2 (COX-2), and various pro-inflammatory cytokines. Curmasip is intended for supportive care in cancer patients to help manage systemic inflammation and potentially enhance the efficacy of standard treatments while supporting overall wellness during and after therapy.
- Brand names
- Curmasip
- Other names
- curcuminturmericCurcumin-MTD
02
Targets
NF-κBTNFA (Tumor necrosis factor alpha (soluble))PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Curmasip.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Curmasip.